Comparison of Insulin Glargine Versus Biphasic Insulin Aspart 30/70 or Biphasic Insulin Aspart 30/70 in Combination With Metformin in Subjects With Type 2 Diabetes.

NCT00184626 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

97

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: biphasic insulin aspart
DRUG: insulin glargine
DRUG: metformin

Sponsor

Novo Nordisk A/S